Cargando…
Translational Research of Telecare for the Treatment of Hepatitis C
Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Met...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071777/ https://www.ncbi.nlm.nih.gov/pubmed/25013762 http://dx.doi.org/10.1155/2014/195097 |
_version_ | 1782322854510985216 |
---|---|
author | Chen, Wan-Lin Chiu, Wen-Ta Wu, Ming-Shun Hsu, Mei-Huang Tsai, Shin-Han |
author_facet | Chen, Wan-Lin Chiu, Wen-Ta Wu, Ming-Shun Hsu, Mei-Huang Tsai, Shin-Han |
author_sort | Chen, Wan-Lin |
collection | PubMed |
description | Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Methods. Two hundred and ninety-eight patients randomly chose either of the two support programs. Group 1 was offered public health nurse consultation at outpatient clinic. Group 2 was offered telecare program with 24 hours of consultation services via a health communication center. All patients were treated with standard therapy and followed up for 72 weeks. Results. Normalization of serum biochemistry was noted in both Group 1 (150 patients) and Group 2 (148 patients). The most common types of side effect in both groups were influenza-like symptoms. Patient compliance was 88% (Group 1) and 94.6% (Group 2). Total dropout cases were 18 (12%) in Group 1 and 8 (5.4%) in Group 2. The program costs were 232,632 USD (Group 1) and 112,500 USD (Group 2). Conclusion. Telecare system with health care communication center model is significant in reducing dropout rate and is more effective with easy access. |
format | Online Article Text |
id | pubmed-4071777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40717772014-07-10 Translational Research of Telecare for the Treatment of Hepatitis C Chen, Wan-Lin Chiu, Wen-Ta Wu, Ming-Shun Hsu, Mei-Huang Tsai, Shin-Han Biomed Res Int Clinical Study Objective. Chronic hepatitis C virus (HCV) infection is a serious health problem in Taiwan. The high dropout rate due to side effects limits the efficacy of treatment. The objective of this study is to investigate the effectiveness of telecare for the treatment of chronic hepatitis. Material and Methods. Two hundred and ninety-eight patients randomly chose either of the two support programs. Group 1 was offered public health nurse consultation at outpatient clinic. Group 2 was offered telecare program with 24 hours of consultation services via a health communication center. All patients were treated with standard therapy and followed up for 72 weeks. Results. Normalization of serum biochemistry was noted in both Group 1 (150 patients) and Group 2 (148 patients). The most common types of side effect in both groups were influenza-like symptoms. Patient compliance was 88% (Group 1) and 94.6% (Group 2). Total dropout cases were 18 (12%) in Group 1 and 8 (5.4%) in Group 2. The program costs were 232,632 USD (Group 1) and 112,500 USD (Group 2). Conclusion. Telecare system with health care communication center model is significant in reducing dropout rate and is more effective with easy access. Hindawi Publishing Corporation 2014 2014-06-10 /pmc/articles/PMC4071777/ /pubmed/25013762 http://dx.doi.org/10.1155/2014/195097 Text en Copyright © 2014 Wan-Lin Chen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Chen, Wan-Lin Chiu, Wen-Ta Wu, Ming-Shun Hsu, Mei-Huang Tsai, Shin-Han Translational Research of Telecare for the Treatment of Hepatitis C |
title | Translational Research of Telecare for the Treatment of Hepatitis C |
title_full | Translational Research of Telecare for the Treatment of Hepatitis C |
title_fullStr | Translational Research of Telecare for the Treatment of Hepatitis C |
title_full_unstemmed | Translational Research of Telecare for the Treatment of Hepatitis C |
title_short | Translational Research of Telecare for the Treatment of Hepatitis C |
title_sort | translational research of telecare for the treatment of hepatitis c |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071777/ https://www.ncbi.nlm.nih.gov/pubmed/25013762 http://dx.doi.org/10.1155/2014/195097 |
work_keys_str_mv | AT chenwanlin translationalresearchoftelecareforthetreatmentofhepatitisc AT chiuwenta translationalresearchoftelecareforthetreatmentofhepatitisc AT wumingshun translationalresearchoftelecareforthetreatmentofhepatitisc AT hsumeihuang translationalresearchoftelecareforthetreatmentofhepatitisc AT tsaishinhan translationalresearchoftelecareforthetreatmentofhepatitisc |